Background illustration for clinical trials search

Influenza Clinical Trials

Browse 153 Influenza clinical trials enrolling across the United States and Canada. 50 people applied to Influenza studies last month. Search by city or state to find one near you.

Filter
1

A Study to Evaluate the Safety and Efficacy of MK-1406/CD388 for Prevention of Influenza (MK-1406-005/CD388.SQ.3.06)

for
Influenza
Location: Burlington MA, Bridgeport CT, Brooklyn NY, Annapolis MD,
Sponsor: Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

Sex: All

Age: 12+

Code: NCT07159763

Phase 3, Recruiting

A Study to Evaluate the Immune Response and Safety of a Vaccine Against Influenza in Adults 18-64 Years of Age

for
Influenza, Human
Location: Hartsdale NY, Miami Lakes FL, Miami FL, Spartanburg SC,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18 - 64

Code: NCT07851246

Phase 3, Recruiting

Clinical Outcomes and Pharmacotherapy Effectiveness in the VA Health Care System (COPE-VA)

for
COVID-19, SARS-CoV-2 Infection, RSV, Influenza
Location: Portland OR
Sponsor: VA Office of Research and Development

Sex: All

Age: 18+

Code: NCT06160128

Recruiting

High vs. Standard Dose Influenza Vaccines in Lung Transplant (Repeater)

for
Immunization; Infection|Transplantation Infection|Influenza,
Location: Nashville TN
Sponsor: Vanderbilt University Medical Center

Sex: All

Age: 18+

Code: NCT07192458

Phase 2, Recruiting

First-in-Human Study of VNT-101: Safety, Tolerability, and Pharmacokinetics

for
Influenza
Location: Overland Park KS
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Sex: All

Age: 18 - 59

Code: NCT07169318

Phase 1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

pH1N1 Blinded Challenge Study

for
Influenza
Location: Baltimore MD, Durham NC
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Sex: All

Age: 18 - 55

Code: NCT07110532

Phase 1, Recruiting

The INFLUENTIAL Trial- Evaluation of National Inpatient Influenza Vaccination Program

for
Influenza
Location: Chicago IL, Seattle WA
Sponsor: University of Colorado, Denver

Sex: All

Age: 0 - 70+

Code: NCT05832307

Recruiting

H5N1 Milk Detection Study

for
Influenza
Location: Atlanta GA
Sponsor: Emory University

Sex: All

Age: 18 - 64

Code: NCT06850298

Recruiting

Quadrivalent Influenza HA Stem Vaccine VRC-FLUMOS0122-00-VP (SteMos1) With and Without ALFQ Adjuvant in Healthy Adults

for
Influenza Prevention, Pandemic Influenza Prevention
Location: Bethesda MD
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Sex: All

Age: 18 - 50

Code: NCT07111078

Phase 1, Recruiting

Optimizing Influenza Vaccination in Surgical Oncology Patients

for
Influenza
Location: Stony Brook NY
Sponsor: Stony Brook University

Sex: All

Age: 18+

Code: NCT01698177

Recruiting

The Effects of Endotracheal Suctioning on Pain and Serum Markers

for
Intensive Care Unit ICU, Intubation, Critical Illness,
Location: Loma Linda CA
Sponsor: Loma Linda University

Sex: All

Age: 18+

Code: NCT06692400

Recruiting

How OMT Benefits Newly Diagnosed Patients With Respiratory Illness When Given Alongside Other Standard Care.

for
Pneumonia, Sinusitis, Bronchitis, Respiratory Disease,
Location: Bloomsburg PA
Sponsor: Geisinger Clinic

Sex: All

Age: 65 - 70+

Code: NCT06495021

Recruiting

Etiologies, Investigations and Outcomes of Patients Presenting With Hemoptysis

for
Hemoptysis, Haemoptysis, Lung Disease, Pneumonia, Tuberculosis,
Location: Sherbrooke
Sponsor: Université de Sherbrooke

Sex: All

Age: 18+

Code: NCT02913365

Recruiting

Microbial Cell-free Metagenomic Sequencing for Suspected Infections in Adult Immunocompromised Outpatients

for
Infection, Infections, Bacterial, Infections, Fungal,
Location: Boston MA, New Orleans LA, Omaha NE
Sponsor: Karius, Inc.

Sex: All

Age: 18+

Code: NCT07110636

Recruiting

Addressing Vaccine Acceptance in Carceral Settings Through Community Engagement

for
COVID-19, Respiratory Viral Infection, Infections, Respiratory
Location: Schwenksville PA
Sponsor: Yale University

Sex: All

Age: 18+

Code: NCT05796505

Recruiting
New

Comprehensive Lung Health

for
Respiratory Illness
Location: Chicago IL
Sponsor: Northwestern University

Sex: All

Age: 21 - 70+

Code: NCT07932717

Recruiting
New

Vocxi Breath Analyzer Study in Pediatric Respiratory Infection

for
Acute Respiratory Illness, Viral Respiratory Infection
Location: Minneapolis MN
Sponsor: University of Minnesota

Sex: All

Age: 7 - 17

Code: NCT07902115

Recruiting

Predictors of Respiratory Failure Following Extubation in the SICU

for
Muscle Weakness, Renal Failure, Respiratory Comorbidities
Location: Boston MA
Sponsor: Massachusetts General Hospital

Sex: All

Age: 18+

Code: NCT01967056

Recruiting

Donor-Derived Viral Specific T-cells (VSTs)

for
Allogeneic Stem Cell Transplant, Viral Infection,
Location: Akron OH, Cincinnati OH
Sponsor: Children's Hospital Medical Center, Cincinnati

Sex: All

Age: 0+

Code: NCT02048332

Phase 1, Phase 2, Recruiting

Third Party Viral Specific T-cells (VSTs)

for
Viral Infection, Viral Reactivation,
Location: Akron OH, Columbus OH, Cincinnati OH
Sponsor: Children's Hospital Medical Center, Cincinnati

Sex: All

Age: 0+

Code: NCT02532452

Phase 2, Recruiting

What is influenza?

Influenza, or flu, is a contagious respiratory infection caused by influenza viruses that spread through coughs, sneezes, and contaminated surfaces. It comes on fast with fever, aches, cough, and exhaustion, and for most people passes within a week or two, but it sends hundreds of thousands of Americans to the hospital in a typical season and is most dangerous for people over 65, young children, pregnant women, and people with heart, lung, or immune conditions. Flu viruses change constantly, which is why the vaccine is reformulated every year and why protection from one season does not carry over to the next.

Antiviral medicines shorten the illness if started within the first two days, and vaccination remains the main way to prevent severe disease. The first mRNA flu vaccine was approved in 2026, and researchers are working toward a universal vaccine that would not need yearly updates. COVID-19 is studied separately on our COVID-19 clinical trials page.

Article preview image

Interested in learning more about flu treatment? Read our guide: Flu Symptoms, Treatment, and Vaccines Explained

Rethinking Influenza: What the Latest Research Shows

Types of influenza clinical trials

Do influenza clinical trials only happen during flu season?

Who can participate in influenza clinical trials?

Do influenza trial participants get paid?

How to enroll in an influenza clinical trial